Login:

username:
password:

New to sessions.thyroid.org?

Create Account

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Conference

Do I Have Access?

Access:

Availability:

Browse by: Sort by:
<< first | < prev next > | last >>
presentations: 1 to 25 of 320
page: of 13 per page
Van Meter Award Lecture
Role of a Thyroid-Specific Long Non-Coding RNA in BRAFV600E Thyroid Carcinoma: Drug Resistance and Iodine Metabolism
Carmelo Nucera, MD, PhD
Harvard Medical School, Boston, MA
from 88th Annual Meeting of the American Thyroid Association on October 4, 2018 8:05 AM-8:50 AM
Paul Starr Award Lecture
Unmasking the Problems with Anti-Thyroid Medication Safety
Scott A. Rivkees, MD
University of Florida - College of Medicine, Gainesville, FL
from 88th Annual Meeting of the American Thyroid Association on October 4, 2018 1:00 PM-1:45 PM
Clark T. Sawin Historical Vignette: The Treatment of Hypothyroidism- from Animal Extracts to Current Controversies
Peter A. Kopp, MD
Northwestern University Feinberg School of Medicine, Chicago, IL
John C. Morris, III, MD
Mayo Clinic College of Medicine, Rochester, MN
Valerie Anne Galton, PhD
Dartmouth Medical School, Lebanon, NH
Jacqueline Jonklaas, MD
Georgetown University Medical Center, Washington, DC
Stephen H. LaFranchi, MD
Oregon Health & Science University, Portland, OR
from 88th Annual Meeting of the American Thyroid Association on October 4, 2018 4:15 PM-4:55 PM
ATA Early Riser Symposium: Transoral Thyroid Surgery - Fad or Here to Stay?
Anatomy and Considerations for Starting Transoral Thyroid
Jonathan O. Russell, MD
Johns Hopkins Hospital, Baltimore, MD
from 88th Annual Meeting of the American Thyroid Association on October 5, 2018 6:30 AM-7:45 AM
ATA Early Riser Symposium: Transoral Thyroid Surgery - Fad or Here to Stay?
Transoral Robotic Vestibular Approach Thyroidectomy (TORTVA)
Hoon Yub Kim, MD
Korea University College of Medicine, Seoul, Korea
from 88th Annual Meeting of the American Thyroid Association on October 5, 2018 6:30 AM-7:45 AM
ATA Early Riser Symposium: TKI's and the Endocrinologist – A Practical Approach to Patient Selection, Dose Adjustment and Side-effect Management
Initiation of TKI Therapy – Drug Choice, Dose Adjustment, OnTherapy Monitoring
Lori J. Wirth, MD
Massachusetts General Hospital, Boston, MA
from 88th Annual Meeting of the American Thyroid Association on October 6, 2018 6:30 AM-7:45 AM
Lewis E. Braverman Award Lecture
Common Clinical Thyroid Cancer Questions in Need of Better Answers
R. Michael Tuttle, MD
Memorial Sloan Kettering Cancer Center, New York, NY
from 88th Annual Meeting of the American Thyroid Association on October 6, 2018 10:45 AM-11:30 AM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
ATA Satellite Symposium Welcome Remarks
Charles H. Emerson, MD
University of Massachusetts School of Medicine, Worchester, Massachusetts
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Program Overview
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Defining the Spectrum of Differentiated Thyroid Cancer: A Clinical Perspective
Lilah F. Morris-Wiseman, MD
Banner University Medical Center, Tucson , Arizona
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Defining the Spectrum of Differentiated Thyroid Cancer: A Histological and Molecular Perspective
Thomas J. Giordano , MD, PhD
University of Michigan, Ann Arbor, Michigan
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Active Surveillance in Differentiated Thyroid Cancer
Wendy Sacks, MD
Cedars-Sinai Medical Center, Los Angeles, California
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Ralph P. Tufano, MD, MBA, FACS
Johns Hopkins University School of Medicine, Baltimore, Maryland
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Mona M. Sabra, MD
Memorial Sloan-Kettering Cancer Center, New York, New York
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Carmen C. Solórzano, MD, FACS
Vanderbilt University, Nashville, Tennessee
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
Stephanie L. Lee, MD, PhD
Boston University Medical Center, Boston, Massachusetts
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
David S. Cooper, MD, MACP
Johns Hopkins University School of Medicine, Baltimore, Maryland
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
Kenneth D. Burman, MD
MedStar Washington Hospital Center, Washington, DC
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Systemic Therapy Options: Standard of Care and Beyond for Advanced Differentiated Thyroid Cancer
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Insights and Surprises from an Online Survey of Thyroid Cancer Patients
Elizabeth Gardner Grubbs, MD, MS, FACS
The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Insights and Surprises from an Online Survey of Thyroid Cancer Patients
Mara Y. Roth, MD
University of Washington, Seattle, Washington
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Questions and Answers
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
from ATA 2018 Satellite Symposium on March 16, 2018 12:55 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Welcome
John C. Morris III, MD
Mayo Clinic, Rochester, MN
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Introduction
Antonio C. Bianco, MD, PhD
Rush University Medical Center, Chicago, IL
Introduction
Jacqueline Jonklaas, MD
Georgetown University Medical Center, Washington, DC
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Understanding the Evolution of Therapies for Hypothyroidism
James V. Hennessey, MD
Beth Israel Deaconess Medical Center, Boston, MA
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Whose Normal TSH is Better, Yours or Mine?
Peter N. Taylor, Bsc, MBChB, MSc
Cardiff University School of Medicine, Cardiff, United Kingdom
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Beyond TSH: T3 Levels and Deiodinase Polymorphisms
Antonio C. Bianco, MD, PhD
Rush University Medical Center, Chicago, IL
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now?
Debate: Where Do We Stand on Combination Therapy?
Douglas S. Ross, MD
Massachusetts General Hospital, Boston, MA
from ATA 2017 Satellite Symposium: Hypothyroidism - Where Are We Now? on March 31, 2017 1:00 PM-5:30 PM
<< first | < prev next > | last >>
presentations: 1 to 25 of 320
page: of 13 per page